Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

• ,
• Ulf Lindström,
• Johan Askling,
• Katerina Chatzidionysiou,
• Nils Feltelius,
• Eva Baecklund,
• Christopher Sjöwall,
• Helena Forsblad-d’Elia,
• Carl Turesson,
• Elisabet Lindqvist,
• Thomas Frisell,
• Alf Kastbom,
• Daniela Di Giuseppe,
• Helena Forsblad-d'Elia,
• Bénédicte Delcoigne,
• Hannah Bower,
• Gerd-Marie Ahlenius,
• Gerd-Marie Alenius

Affiliations

Ulf Lindström

Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Johan Askling

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Katerina Chatzidionysiou

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Nils Feltelius

Swedish Medical Products Agency, Uppsala, Sweden

Eva Baecklund

Unit of Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Christopher Sjöwall

Department of Biomedical and Clinical Sciences, Linköping University, Linkoping, Sweden

Helena Forsblad-d’Elia

Carl Turesson

Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden

Elisabet Lindqvist

Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden

Thomas Frisell

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Alf Kastbom

Department of Biomedical and Clinical Sciences, Linkopings Universitet, Linkoping, Sweden

Daniela Di Giuseppe

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Helena Forsblad-d'Elia

Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Bénédicte Delcoigne

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Hannah Bower

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Gerd-Marie Ahlenius

Gerd-Marie Alenius

Department of Public Health and Clinical Medicine/Rheumatology, Umeå Universitet, Umeå, Sweden